Neuroleptic malignant syndrome in COVID-19 patients by Soh et al

被引:0
|
作者
Ubhayakar, Nitin [1 ]
Liu, Antonio [1 ]
机构
[1] Adventist Hlth White Mem, Los Angeles, CA 90033 USA
来源
关键词
D O I
10.1016/j.ajem.2020.06.038
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:259 / 259
页数:1
相关论文
共 50 条
  • [21] Antiphospholipid autoantibodies and thrombosis in patients with COVID-19: comment on the article by Bertin et al
    Frapard, T.
    Hue, S.
    Rial, C.
    de Prost, N.
    Mekontso Dessap, A.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 897 - 899
  • [22] Response to: 'Patients with lupus with COVID-19: University of Michigan experience' by Wallace et al
    Mathian, Alexis
    Amoura, Zahir
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03)
  • [23] Comment on Hu et al: The cytokine storm and COVID-19
    Faqihi, Fahad
    Alharthy, Abdulrahman
    Memish, Ziad A.
    Karakitsos, Dimitrios
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 631 - 633
  • [24] Neuroleptic Malignant Syndrome due to Atypical Antipsychotic in COVID-19-positive Pregnant Woman
    Burad, Jyoti
    Kodange, Sonali
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2021, 25 (09) : 1073 - 1074
  • [25] The evaluation and management of patients with neuroleptic malignant syndrome
    Bhanushali, MJ
    Tuite, PJ
    NEUROLOGIC CLINICS, 2004, 22 (02) : 389 - +
  • [26] Malignant hyperthermia susceptibility three patients with malignant neuroleptic syndrome
    Silva, HCA
    Bahia, VS
    Oliveira, RAA
    Marchiori, PE
    Scaff, M
    Tsanaclis, AMC
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2000, 58 (3A) : 713 - 719
  • [27] 20 NEUROLEPTIC RECHALLENGES AFTER NEUROLEPTIC MALIGNANT SYNDROME IN 15 PATIENTS
    ROSEBUSH, PI
    STEWART, TD
    GELENBERG, AJ
    JOURNAL OF CLINICAL PSYCHIATRY, 1989, 50 (08) : 295 - 298
  • [28] Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al
    Mathian, Alexis
    Amoura, Zahir
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (02)
  • [29] Euthyroid Sick Syndrome in Patients With COVID-19
    Zou, Runmei
    Wu, Chenfang
    Zhang, Siye
    Wang, Guyi
    Zhang, Quan
    Yu, Bo
    Wu, Ying
    Dong, Haiyun
    Wu, Guobao
    Wu, Shangjie
    Zhong, Yanjun
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [30] Re: Remdesivir for the treatment of COVID-19 by Lee et al.
    Beccacece, Alessia
    Bartoli, Tommaso Ascoli
    Nicastri, Emanuele
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (01) : 114 - 114